Inside the research
BrightSpring Health Services, Inc.
BTSG Research profile · latest available data
Price overview
$56.59
▲ +0.57 (+1.0%)
| 52w hi | $72.91 |
|---|---|
| 52w lo | $26.85 |
| Vol | 2.08M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.15
| Short | -0.04 |
|---|---|
| Medium | +0.25 |
| Long | +0.32 |
computed 2026-09-27
Key fundamentals
BrightSpring Health Services, Inc.
Healthcare · Health Information Services
| Market cap | $11.20B |
|---|---|
| Enterprise value | $13.51B |
| Trailing P/E | 50.53x |
| Forward P/E | 24.84x |
| EV / EBITDA | 21.55x |
| P / S (ttm) | 0.78x |
| Profit margin | 2.5% |
| Return on equity | 13.0% |
| Revenue growth | +23.0% |
| Earnings growth | +196.6% |
| Debt / equity | 116.01 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.26 | |
| Sector | +0.08 | |
| Technical | -0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
Risk Metrics
| Beta vs SPX | 1.19 |
|---|---|
| Corr SPX | 0.41 |
| Annual vol | 46.3% |
| Annual ret | +78.0% |
| Sharpe | 1.69 |
| Max DD | -35.6% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $60.53 |
|---|---|
| High / Low | $65.00 / $49.00 |
| Median | $61.00 |
| Analysts | 15 |
| Strong Buy | 2 | |
|---|---|---|
| Buy | 14 | |
| Hold | 0 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-06 | Morgan Stanley | → Overweight |
| 2026-05-05 | Mizuho | → Outperform |
| 2026-05-04 | Wells Fargo | → Overweight |
| 2026-05-04 | TD Cowen | → Buy |
| 2026-05-04 | Stephens & Co. | → Overweight |
| 2026-05-04 | Keybanc | → Overweight |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-31 | Earnings Release, Exhibits | read |
| 2026-06-12 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-06-05 | Material Agreement, Exhibits | read |
| 2026-05-21 | Shareholder Vote | read |
| 2026-05-01 | Earnings Release, Exhibits | read |
| 2026-03-31 | Acquisition / Disposition, Officer / Director Change… | read |
| 2026-03-04 | Material Agreement, Exhibits | read |
| 2026-02-27 | Earnings Release, Exhibits | read |
| 2025-10-28 | Earnings Release, Exhibits | read |
| 2025-10-22 | Material Agreement, Exhibits | read |
| 2025-10-20 | Earnings Release, Exhibits | read |
| 2025-08-01 | Earnings Release, Exhibits | read |
SEC Filings
The Long Run
FY 2024–2025 · 2 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $10.07B | +14.1% | |
| Gross profit | $1.52B | -4.4% | |
| Operating income | $295.25M | +57.2% | |
| Net income | $190.67M | — | |
| Cash from ops | $490.17M | — |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $56.36 | $57.01 | $55.49 | $56.59 | 2.08M |
| Sep 24 | $55.54 | $56.42 | $54.87 | $56.02 | 2.43M |
| Sep 23 | $56.04 | $56.78 | $55.52 | $55.78 | 1.73M |
| Sep 22 | $56.10 | $57.05 | $55.81 | $56.55 | 2.07M |
| Sep 21 | $56.79 | $56.96 | $55.35 | $55.86 | 2.66M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →